会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • 7-옥소-2,3,7,14-테트라히드로-1H-벤조[b]피라노[3,2-h]아크리딘 카르복실레이트의 화합물, 이것의 제조 방법 및이를 함유하는 약제 조성물
    • 7-옥소-2,3,7,14-테트라히드로중벤조[b]피라노[3,2-h]아크리딘카르실레이트의화합물,이것의제조방법및이를함유하는약제조성물
    • KR100433706B1
    • 2004-05-31
    • KR1020000033220
    • 2000-06-16
    • 르 라보레또레 쎄르비에르
    • 코스,미셸틸레껭,프랑스와미셸,실비에아타시,가넴피에르,알렝레나르드,피에르프페이페르,브루노
    • C07D491/00
    • C07D491/04
    • 7-Oxo-2,3,7,14-tetrahydro-1H-benzo(b)pyrano(3,2-h) acridine derivatives (I), their salts with acids and bases, their isomers, N-oxides, their preparation, and pharmaceutical compositions containing them. The new compounds are of formula (I) X and Y = H, halogen, OH, SH, CN, NO2, 1-6C alkyl, alkoxy, or trihaloalkyl, amino (optionally by one or two 1-6C alkyl groups which may be substituted by alkoxy groups or by a group of formula NR7R8) or together form a methylenedioxy or ethylene dioxy group, the groups X and Y being present on either of the two adjacent benzene rings; R7 and R8 = H or 1-6C alkyl, aryl, or aralkyl; R1 = H or 1-6C alkyl; R2 = H, OH, 1-6C alkyl or alkoxy (optionally substituted by NR9R10, or by a 5-7 membered saturated or unsaturated mono- or bicyclic heterocycle having one or two hetero atoms selected from O, N, and S), alkyl carbonyloxy, or amino (optionally substituted by one or two alkyl, aryl, or aralkyl groups, an alkylcarbonyl group that may be substituted by NR7R8, a group -R11-NR9R10, an alkylene group substituted by a heterocycle, or a group -R11-CO-R12; R9 and R10 = H, or 1-6C alkyl or hydroxyalkyl; R11 = 1-6C alkylene; R12 = OH or 1-6C alkoxy; R3 and R4 = H or 1-6C alkyl; one or both of R5 and R6 = a group -O-CO-U-V, and if only one has this meaning the other represents a group Z; U = 1-8C alkylene, optionally substituted by one or more groups selected from aryl, OH, or 1-6C alkoxy; V = COOH, COOR13, OH, 1-6C alkoxy, -NR7R8, -NR7-COOR13, -NR7-CO-R13, -COR13, or CONR7R8; R13 = 1-6C alkyl optionally substituted OH, aryl, or aralkyl; Z = OH, 1-6C alkoxy, alkoxycarbonyl, alkylcarbonyloxy, arylcarbonyloxy, arylalkyl carbonyloxy, or amino optionally substituted by one or two alkyl groups
    • 7-氧代-2,3,7,14-四氢-1H-苯并(b)吡喃并(3,2-h)吖啶衍生物(I),它们与酸和碱的盐,它们的异构体,N-氧化物,它们的制备 和含有它们的药物组合物。 新化合物具有式(I)X和Y = H,卤素,OH,SH,CN,NO 2,1-6C烷基,烷氧基或三卤代烷基,氨基(任选地被一个或两个1-6C烷基 被烷氧基取代或被式NR7R8基团取代)或一起形成亚甲基二氧基或亚乙基二氧基,基团X和Y存在于两个相邻苯环中的任一个上; R7和R8 = H或1-6C烷基,芳基或芳烷基; R1 = H或1-6C烷基; R2 = H,OH,1-6C烷基或烷氧基(任选被NR9R10取代,或被具有一个或两个选自O,N和S的杂原子的5-7元饱和或不饱和单环或双环杂环取代),烷基 羰基氧基或氨基(任选被一个或两个烷基,芳基或芳烷基取代,可被NR7R8取代的烷基羰基,基团-R11-NR9R10,被杂环取代的亚烷基或基团-R11- CO-R12; R9和R10 = H或1-6C烷基或羟烷基; R11 = 1-6C亚烷基; R12 = OH或1-6C烷氧基; R3和R4 = H或1-6C烷基; R5 和R6 =基团-O-CO-UV,并且如果只有一个具有该含义,则另一个表示基团Z; U = 1-8C亚烷基,任选被一个或多个选自芳基,OH或1-6C 烷氧基; V = COOH,COOR13,OH,1-6C烷氧基,-NR7R8,-NR7-COOR13,-NR7-CO-R13,-COR13或CONR7R8; R13 = 1-6C烷基,任选取代的OH,芳基或芳烷基 ; Z = OH,1-6C烷氧基,烷氧基羰基,烷基羰基氧基,芳基 羰基氧基,芳基烷基羰基氧基或任选被一个或两个烷基取代的氨基